An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer

Francesca Milano, Agnieszka M. Rygiel, Navtej Singh Buttar, Jacques J G H M Bergman, Carine Sondermeijer, Jantine W P M Van Baal, Anja Ten Brinke, Martien Kapsenberg, S. Marieke Van Ham, Maikel P. Peppelenbosch, Kausilia K. Krishnadath

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Esophageal cancer is a highly malignant disease that despite surgery and adjuvant therapies has an extremely poor outcome. Dendritic cell (DC) immunotherapy as a novel promising strategy could be an alternative for treating this malignancy. Effective DC-mediated immune responses can be achieved by raising cytotoxic T lymphocyte (CTL) response against multiple antigens through loading DCs with total tumor RNA. However, the efficacy of this strategy first needs to be evaluated in a pre-clinical setting. The aim of the study was to set up an ex vivo autologous human readout assay for assessing the effects of DC-mediated cytotoxic responses, using total tumor RNA as an antigen load. Biopsy specimens of seven esophageal cancer patients were used to establish primary cultures of normal and cancer cells and to obtain autologous RNA for loading DCs. Mature DCs loaded with either normal or tumor RNA were obtained and subsequently used to raise various lymphocytes populations. Apoptosis levels of the autologous cultures were measured before and after incubating the cultures with the different lymphocytes populations. The mean apoptosis levels in the tumor cell cultures, induced by lymphocytes instructed by DCs loaded with tumor RNA, significantly increased with 15.6% ±2.9 SEM (range 3.4-24.5%, t-test, P < 0.05). Incubation of the normal cultures with the lymphocytes populations showed a mean non-significant increase in apoptosis of 0.4% ±3.4 SEM (range -13.9 to 9.8%, t-test, P = 0.7). Here, we introduce a practical, patient-specific autologous readout assay for pre-clinical testing of DC-mediated cytotoxic responses. Additionally, we demonstrated that the use of autologous tumor RNA as a strategy for raising cytotoxic responses against multiple tumor antigens could be effective for treating esophageal cancer.

Original languageEnglish (US)
Pages (from-to)1967-1977
Number of pages11
JournalCancer Immunology, Immunotherapy
Volume56
Issue number12
DOIs
StatePublished - Dec 2007

Fingerprint

Cytotoxic T-Lymphocytes
Esophageal Neoplasms
Dendritic Cells
RNA
Neoplasms
Lymphocytes
Apoptosis
Population
Antigens
Neoplasm Antigens
Immunotherapy
Cell Culture Techniques
Biopsy

Keywords

  • Apoptosis
  • Cytotoxic T-cells
  • Dendritic cells
  • Esophageal adenocarcinoma
  • Immunotherapy
  • RNA electroporation

ASJC Scopus subject areas

  • Cancer Research
  • Immunology
  • Oncology

Cite this

Milano, F., Rygiel, A. M., Buttar, N. S., Bergman, J. J. G. H. M., Sondermeijer, C., Van Baal, J. W. P. M., ... Krishnadath, K. K. (2007). An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer. Cancer Immunology, Immunotherapy, 56(12), 1967-1977. https://doi.org/10.1007/s00262-007-0341-0

An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer. / Milano, Francesca; Rygiel, Agnieszka M.; Buttar, Navtej Singh; Bergman, Jacques J G H M; Sondermeijer, Carine; Van Baal, Jantine W P M; Ten Brinke, Anja; Kapsenberg, Martien; Van Ham, S. Marieke; Peppelenbosch, Maikel P.; Krishnadath, Kausilia K.

In: Cancer Immunology, Immunotherapy, Vol. 56, No. 12, 12.2007, p. 1967-1977.

Research output: Contribution to journalArticle

Milano, F, Rygiel, AM, Buttar, NS, Bergman, JJGHM, Sondermeijer, C, Van Baal, JWPM, Ten Brinke, A, Kapsenberg, M, Van Ham, SM, Peppelenbosch, MP & Krishnadath, KK 2007, 'An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer', Cancer Immunology, Immunotherapy, vol. 56, no. 12, pp. 1967-1977. https://doi.org/10.1007/s00262-007-0341-0
Milano, Francesca ; Rygiel, Agnieszka M. ; Buttar, Navtej Singh ; Bergman, Jacques J G H M ; Sondermeijer, Carine ; Van Baal, Jantine W P M ; Ten Brinke, Anja ; Kapsenberg, Martien ; Van Ham, S. Marieke ; Peppelenbosch, Maikel P. ; Krishnadath, Kausilia K. / An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer. In: Cancer Immunology, Immunotherapy. 2007 ; Vol. 56, No. 12. pp. 1967-1977.
@article{c541d719a9e041d9be5ee4d5e7b4b482,
title = "An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer",
abstract = "Esophageal cancer is a highly malignant disease that despite surgery and adjuvant therapies has an extremely poor outcome. Dendritic cell (DC) immunotherapy as a novel promising strategy could be an alternative for treating this malignancy. Effective DC-mediated immune responses can be achieved by raising cytotoxic T lymphocyte (CTL) response against multiple antigens through loading DCs with total tumor RNA. However, the efficacy of this strategy first needs to be evaluated in a pre-clinical setting. The aim of the study was to set up an ex vivo autologous human readout assay for assessing the effects of DC-mediated cytotoxic responses, using total tumor RNA as an antigen load. Biopsy specimens of seven esophageal cancer patients were used to establish primary cultures of normal and cancer cells and to obtain autologous RNA for loading DCs. Mature DCs loaded with either normal or tumor RNA were obtained and subsequently used to raise various lymphocytes populations. Apoptosis levels of the autologous cultures were measured before and after incubating the cultures with the different lymphocytes populations. The mean apoptosis levels in the tumor cell cultures, induced by lymphocytes instructed by DCs loaded with tumor RNA, significantly increased with 15.6{\%} ±2.9 SEM (range 3.4-24.5{\%}, t-test, P < 0.05). Incubation of the normal cultures with the lymphocytes populations showed a mean non-significant increase in apoptosis of 0.4{\%} ±3.4 SEM (range -13.9 to 9.8{\%}, t-test, P = 0.7). Here, we introduce a practical, patient-specific autologous readout assay for pre-clinical testing of DC-mediated cytotoxic responses. Additionally, we demonstrated that the use of autologous tumor RNA as a strategy for raising cytotoxic responses against multiple tumor antigens could be effective for treating esophageal cancer.",
keywords = "Apoptosis, Cytotoxic T-cells, Dendritic cells, Esophageal adenocarcinoma, Immunotherapy, RNA electroporation",
author = "Francesca Milano and Rygiel, {Agnieszka M.} and Buttar, {Navtej Singh} and Bergman, {Jacques J G H M} and Carine Sondermeijer and {Van Baal}, {Jantine W P M} and {Ten Brinke}, Anja and Martien Kapsenberg and {Van Ham}, {S. Marieke} and Peppelenbosch, {Maikel P.} and Krishnadath, {Kausilia K.}",
year = "2007",
month = "12",
doi = "10.1007/s00262-007-0341-0",
language = "English (US)",
volume = "56",
pages = "1967--1977",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "12",

}

TY - JOUR

T1 - An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer

AU - Milano, Francesca

AU - Rygiel, Agnieszka M.

AU - Buttar, Navtej Singh

AU - Bergman, Jacques J G H M

AU - Sondermeijer, Carine

AU - Van Baal, Jantine W P M

AU - Ten Brinke, Anja

AU - Kapsenberg, Martien

AU - Van Ham, S. Marieke

AU - Peppelenbosch, Maikel P.

AU - Krishnadath, Kausilia K.

PY - 2007/12

Y1 - 2007/12

N2 - Esophageal cancer is a highly malignant disease that despite surgery and adjuvant therapies has an extremely poor outcome. Dendritic cell (DC) immunotherapy as a novel promising strategy could be an alternative for treating this malignancy. Effective DC-mediated immune responses can be achieved by raising cytotoxic T lymphocyte (CTL) response against multiple antigens through loading DCs with total tumor RNA. However, the efficacy of this strategy first needs to be evaluated in a pre-clinical setting. The aim of the study was to set up an ex vivo autologous human readout assay for assessing the effects of DC-mediated cytotoxic responses, using total tumor RNA as an antigen load. Biopsy specimens of seven esophageal cancer patients were used to establish primary cultures of normal and cancer cells and to obtain autologous RNA for loading DCs. Mature DCs loaded with either normal or tumor RNA were obtained and subsequently used to raise various lymphocytes populations. Apoptosis levels of the autologous cultures were measured before and after incubating the cultures with the different lymphocytes populations. The mean apoptosis levels in the tumor cell cultures, induced by lymphocytes instructed by DCs loaded with tumor RNA, significantly increased with 15.6% ±2.9 SEM (range 3.4-24.5%, t-test, P < 0.05). Incubation of the normal cultures with the lymphocytes populations showed a mean non-significant increase in apoptosis of 0.4% ±3.4 SEM (range -13.9 to 9.8%, t-test, P = 0.7). Here, we introduce a practical, patient-specific autologous readout assay for pre-clinical testing of DC-mediated cytotoxic responses. Additionally, we demonstrated that the use of autologous tumor RNA as a strategy for raising cytotoxic responses against multiple tumor antigens could be effective for treating esophageal cancer.

AB - Esophageal cancer is a highly malignant disease that despite surgery and adjuvant therapies has an extremely poor outcome. Dendritic cell (DC) immunotherapy as a novel promising strategy could be an alternative for treating this malignancy. Effective DC-mediated immune responses can be achieved by raising cytotoxic T lymphocyte (CTL) response against multiple antigens through loading DCs with total tumor RNA. However, the efficacy of this strategy first needs to be evaluated in a pre-clinical setting. The aim of the study was to set up an ex vivo autologous human readout assay for assessing the effects of DC-mediated cytotoxic responses, using total tumor RNA as an antigen load. Biopsy specimens of seven esophageal cancer patients were used to establish primary cultures of normal and cancer cells and to obtain autologous RNA for loading DCs. Mature DCs loaded with either normal or tumor RNA were obtained and subsequently used to raise various lymphocytes populations. Apoptosis levels of the autologous cultures were measured before and after incubating the cultures with the different lymphocytes populations. The mean apoptosis levels in the tumor cell cultures, induced by lymphocytes instructed by DCs loaded with tumor RNA, significantly increased with 15.6% ±2.9 SEM (range 3.4-24.5%, t-test, P < 0.05). Incubation of the normal cultures with the lymphocytes populations showed a mean non-significant increase in apoptosis of 0.4% ±3.4 SEM (range -13.9 to 9.8%, t-test, P = 0.7). Here, we introduce a practical, patient-specific autologous readout assay for pre-clinical testing of DC-mediated cytotoxic responses. Additionally, we demonstrated that the use of autologous tumor RNA as a strategy for raising cytotoxic responses against multiple tumor antigens could be effective for treating esophageal cancer.

KW - Apoptosis

KW - Cytotoxic T-cells

KW - Dendritic cells

KW - Esophageal adenocarcinoma

KW - Immunotherapy

KW - RNA electroporation

UR - http://www.scopus.com/inward/record.url?scp=34848833254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848833254&partnerID=8YFLogxK

U2 - 10.1007/s00262-007-0341-0

DO - 10.1007/s00262-007-0341-0

M3 - Article

VL - 56

SP - 1967

EP - 1977

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 12

ER -